Patent map and technology intelligence report. PeptidesIntellectual Property ExchangeJanuary 24, 2010 15 Pages - SKU: ITR2582692 |
| General processes for the preparation of peptides; Peptides of undefined number of amino acids; Derivatives thereof; Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof; Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof; Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof; Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Immunoglobulins, e.g. monoclonal or polyclonal antibodies; Carrier-bound or immobilized peptides; Preparation thereof; Hybrid peptides. |
Related Markets
Drug Discovery Reports
- Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012
